AsclepiX is a startup based in the United States, most recent round Series A, 1 tracked investor.
Based in the United States, AsclepiX is a startup founded in 2019. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
vascular homeostasis peptide regulators discovery to treat retinal and other diseases
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.